Demonstration of non-inferiority of a novel combination intramammary antimicrobial in the treatment of clinical mastitis

AIM: To test the non-inferiority of a novel combination intramammary product containing penicillin and cloxacillin to a reference intramammary product containing oxytetracycline, oleandomycin, neomycin and prednisolone with regard to bacteriological cure and clinical cure.

METHODS: Clinical cases of mastitis were sourced from 30 spring-calving dairy farms in the Southland region of New Zealand. Affected quarters were infused three times at 24 hourly intervals with either the novel combination product containing 1?g penicillin and 200?mg cloxacillin, or a reference product containing 200?mg oxytetracycline, 100?mg oleandomycin, 100?mg neomycin and 5?mg prednisolone. Cows were enrolled when a farmer detected a case of clinical mastitis. Milk samples were collected for microbiological culture immediately before treatment (Day 0) and on Days 9, 16 and 23. Bacteriological cure was compared for 187 and 178 quarters treated with the reference and novel product, respectively, and clinical cure was compared for 235 and 223 quarters, respectively. Non-inferiority was assessed by calculating the difference in cure rates between the two products and constructing a 95% CI around the difference, using the variance inflation factor to account for herd level clustering. The non-inferiority margin was 20% for both bacteriological and clinical cure. Generalising estimating equation models were used to determine predictor variables.

RESULTS: The bacteriological cure percentage, adjusted to account for herd-level clustering, was 8.5 (95% CI=?1.7–21.8)% higher for quarters treated with the novel than the reference product. The adjusted clinical cure percentage was 0.3 (95% CI=?11.2–12.0)% higher for clinical quarters treated with the novel than the reference product. Bacterial species was the only covariate for bacteriological cure (p=0.003), and quarter score at enrolment (indicating udder inflammation) was the only covariate for clinical cure (p=0.032) in the multivariable models.

CONCLUSION: The novel combination product was demonstrated to be non-inferior to the reference product with regards to both bacteriological cure and clinical cure.

CLINICAL RELEVANCE: Clinicians treating mastitis now have access to this novel combination intramammary product, and demonstration of its non-inferiority compared to the existing reference product will provide options for treatment approaches. The novel product contains fewer antimicrobials; which are of a narrower spectrum of activity.     

Mitigating sea turtle by-catch in coastal passive net fisheries

There is growing evidence that small-scale, coastal, passive net fisheries may be the largest single threat to some sea turtle populations. We review assessments of turtle interactions in these fisheries, and experiments on gear-technology approaches (modifying gear designs, materials and fishing methods) to mitigate turtle by-catch, available from a small number of studies and fisheries. Additional assessments are needed to improve the limited understanding of the relative degree of risk coastal net fisheries pose to turtle populations, to prioritize limited conservation resources and identify suitable mitigation opportunities. Whether gear technology provides effective and commercially viable solutions, alone or in combination with other approaches, is not well-understood. Fishery-specific assessments and trials are needed, as differences between fisheries, including in gear designs; turtle and target species, sizes and abundance; socioeconomic context; and practicality affect efficacy and suitability of by-catch mitigation methods. Promising gear-technology approaches for gillnets and trammel nets include: increasing gear visibility to turtles but not target species, through illumination and line materials; reducing net vertical height; increasing tiedown length or eliminating tiedowns; incorporating shark-shaped silhouettes; and modifying float characteristics, the number of floats or eliminating floats. Promising gear-technology approaches for pound nets and other trap gear include: replacing mesh with ropes in the upper portion of leaders; incorporating a turtle releasing device into traps; modifying the shape of the trap roof to direct turtles towards the location of an escapement device; using an open trap; and incorporating a device to prevent sea turtle entrance into traps.     

芦荟粉对不同性别肉仔鸡免疫机能及生产性能的影响

选用1日龄AA肉仔鸡共设雄性对照组(Ⅰ)、雄性芦荟粉组(Ⅱ)、雌性对照组(Ⅲ)和雌性芦荟粉组(Ⅳ)4个处理,Ⅰ、Ⅲ组饲喂基础日粮,Ⅱ、Ⅳ组均在基础日粮中添加600 mg.kg-1的芦荟粉。结果表明:雄性芦荟粉组比雄性对照组极显著降低了料肉比(P<0.01);21 d雄性芦荟粉组脾脏指数显著高于对照组(P<0.05);21 d雄性芦荟粉组新城疫血凝抑制效价显著高于对照组(P<0.05);42 d雄性芦荟粉组自然杀伤细胞杀伤活性极显著高于对照组(P<0.01)。说明日粮中添加芦荟粉可以提高肉仔鸡生产性能和免疫机能,且对雄性肉仔鸡生产性能和免疫机能影响效果优于雌性。